Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Operations

v3.26.1
Consolidated Statements of Operations - USD ($)
shares in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating expenses:    
Research and development $ 5,055,000 $ 12,537,000
General and administrative 3,964,000 5,341,000
Total operating expenses 9,019,000 17,878,000
Loss from operations (9,019,000) (17,878,000)
Other income (expense):    
Interest income, net 134,000 537,000
Foreign exchange gain (loss) 54,000 (163,000)
Total other income, net 188,000 374,000
Net loss $ (8,831,000) $ (17,504,000)
Net loss per common share, basic $ (0.78) $ (1.72)
Net loss per common share, diluted $ (0.78) $ (1.72)
Weighted average number of common shares outstanding, basic 11,290 10,174
Weighted average number of common shares outstanding, diluted 11,290 10,174